Skip to main content

Fitzgerald Kevin Joseph

In the past year, 5 open-market sale filings worth $9.63M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$9.63M
5 filings
Net
−$9.63M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Fitzgerald Kevin Joseph as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ALNY Alnylam Pharmaceuticals, Inc.

CSO & EVP, Head of Research13 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 26, 2024 (view filing)Jun 251 dayFitzgerald Kevin JosephCSO & EVP, Head of ResearchSSale−1.20K$230.99−$276.7K−7.8%14.2K after12 lots
Aug 14, 2024 (view filing)Aug 122 daysFitzgerald Kevin JosephCSO & EVP, Head of ResearchSSale−22.0K$270.99−$5.97M−63.1%12.9K after6 lots10b5-1
Nov 27, 2024 (view filing)Nov 26-271 dayFitzgerald Kevin JosephCSO & EVP, Head of ResearchSSale−3.00K$251.65−$754.9K−18.9%12.9K after9 lots10b5-1
Feb 18, 2025 (view filing)Feb 14-184 daysFitzgerald Kevin JosephCSO & EVP, Head of ResearchSSale−2.10K$252.71−$531.4K−14.0%12.9K after17 lots10b5-1
Mar 3, 2025 (view filing)Feb 283 daysFitzgerald Kevin JosephCSO & EVP, Head of ResearchSSale−496$241.69−$119.9K−3.9%12.4K after8 lots
Mar 5, 2025 (view filing)Mar 3-42 daysFitzgerald Kevin JosephCSO & EVP, Head of ResearchSSale−2.75K$242.94−$669.3K−16.9%13.5K after14 lots10b5-1
Aug 19, 2025 (view filing)Aug 181 dayFitzgerald Kevin JosephCSO & EVP, Head of ResearchSSale−1.40K$453.27−$632.8K−5.8%22.7K after8 lots
Oct 3, 2025 (view filing)Oct 21 dayFitzgerald Kevin JosephCSO & EVP, Head of ResearchSSale−2.44K$452.05−$1.10M−8.8%25.2K after12 lots
Nov 19, 2025 (view filing)Nov 172 daysFitzgerald Kevin JosephCSO & EVP, Head of ResearchSSale−12.1K$452.18−$5.48M−36.3%21.3K after11 lots10b5-1
Jan 14, 2026 (view filing)Jan 12-132 daysFitzgerald Kevin JosephCSO & EVP, Head of ResearchSSale−3.80K$367.37−$1.40M−15.2%21.3K after27 lots10b5-1

See all 13 trades at ALNY